Clinical Trials and Management of Osteochondral Lesions

Adv Exp Med Biol. 2018:1058:391-413. doi: 10.1007/978-3-319-76711-6_18.

Abstract

Osteochondral lesions are frequent and important causes of pain and disability. These lesions are induced by traumatic injuries or by diseases that affect both the cartilage surface and the subchondral bone. Due to the limited cartilage ability to regenerate and self-repair, these lesions tend to gradually worsen and progress towards osteoarthritis. The clinical, social, and economic impact of the osteochondral lesions is impressive and although therapeutic alternatives are under discussion, a consensus is not yet been achieved. Over the previous decade, new strategies based on innovative tissue engineering approaches have been developed with promising results. However, in order those products reach the market and help the actual patient in an effective manner, there is still a lot of work to be done. The current state of the implications, clinical aspects, and available treatments for this pathology, as well as the ongoing preclinical and clinical trials are presented in this chapter.

Keywords: Bone repair; Cartilage repair; Clinical studies; Musculoskeletal injuries; Osteochondral; Tissue engineering.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Bone and Bones* / injuries
  • Bone and Bones* / metabolism
  • Bone and Bones* / pathology
  • Cartilage* / injuries
  • Cartilage* / metabolism
  • Cartilage* / pathology
  • Clinical Trials as Topic
  • Humans
  • Osteoarthritis* / genetics
  • Osteoarthritis* / metabolism
  • Osteoarthritis* / pathology
  • Osteoarthritis* / therapy
  • Tissue Engineering / methods*